Succinoylamino lactams as inhibitors of ABeta protein production
Details for Australian Patent Application No. 2003203805 (hide)
International Classifications
Event Publications
15 May 2003 Complete Application Filed
12 June 2003 Application Open to Public Inspection
Published as AU-B-2003203805
10 November 2005 Change of Name(s) of Applicant(s), Section 104
Du Pont Pharmaceuticals Company The name of the applicant has been changed to Bristol-Myers Squibb Pharma Company
4 January 2007 Application Accepted
Published as AU-B-2003203805
15 February 2007 Corrigenda
Applications Accepted - Name Index Under the name Bristol-Myers Squibb Pharma Company, Application No. 2003203805, under INID (72) correct the co-inventor name to read Thompson, Lorin Andrew
3 May 2007 Standard Patent Sealed
3 March 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser